Literature DB >> 1961762

Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria.

J S Lee1, M Anvret.   

Abstract

Acute intermittent porphyria (AIP) is a metabolic disorder characterized by a partial deficiency of the porphobilinogen deaminase (PBGD, EC 4.3.1.8) activity. Previous haplotype analysis combined with genealogical data suggested a common origin of the PBGD gene mutation in the AIP families originating from northern Sweden (Lappland), where the highest prevalence of the disease (1 in 1500) is observed. An AIP family from Lappland consisting of two patients and two unaffected subjects was investigated. The genomic DNA fragments of the PBGD gene were amplified by polymerase chain reaction (PCR) and directly sequenced, and the sequence of the coding region was compared with the normal sequence to identify the mutation. A base substitution, G to A, in exon 10 of the PBGD gene was identified. The mutation changes the codon for Trp198 to a stop codon (nonsense mutation) and creates a recognition site for the restriction enzyme Nhe I. Screening of 33 Swedish AIP families showed that 15 had this mutation. Genealogical data revealed that 12 of the 15 families were related to the northern family. This finding supports the hypothesis of a "founder effect" of the mutation in the families originating from Lappland. In addition, a method is described for detection of specific sequences in the genome by one-sided PCR using Taq polymerase. This method is simple, fast, and economical and can be substituted for hybridization analysis using allele-specific oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961762      PMCID: PMC53042          DOI: 10.1073/pnas.88.23.10912

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyria.

Authors:  J S Lee; G Lundin; L Lannfelt; L Forsell; C Picat; B Grandchamp; M Anvret
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria.

Authors:  J S Lee; M Anvret; J Lindsten; L Lannfelt; P Gellerfors; L Wetterberg; Y Floderus; S Thunell
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

Review 3.  Structural hemoglobin variants that produce the phenotype of thalassemia.

Authors:  J G Adams; M B Coleman
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

4.  A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyria.

Authors:  B Grandchamp; C Picat; F de Rooij; C Beaumont; P Wilson; J C Deybach; Y Nordmann
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

5.  Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrate.

Authors:  R J Desnick; L T Ostasiewicz; P A Tishler; P Mustajoki
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Acute intermittent porphyria caused by a C----T mutation that produces a stop codon in the porphobilinogen deaminase gene.

Authors:  G A Scobie; D H Llewellyn; A J Urquhart; S J Smyth; N A Kalsheker; P R Harrison; G H Elder
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  Nonsense mutations in the human beta-globin gene affect mRNA metabolism.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  Tissue-specific splicing mutation in acute intermittent porphyria.

Authors:  B Grandchamp; C Picat; V Mignotte; J H Wilson; K Te Velde; L Sandkuyl; P H Roméo; M Goossens; Y Nordmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria.

Authors:  D H Llewellyn; G H Elder; N A Kalsheker; O W Marsh; P R Harrison; B Grandchamp; C Picat; Y Nordmann; P H Romeo; M Goossens
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

10.  Haplotyping of the human porphobilinogen deaminase gene in acute intermittent porphyria by polymerase chain reaction.

Authors:  J S Lee; J Lindsten; M Anvret
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

View more
  25 in total

1.  Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).

Authors:  C Solis; I Lopez-Echaniz; D Sefarty-Graneda; K H Astrin; R J Desnick
Journal:  Mol Med       Date:  1999-10       Impact factor: 6.354

Review 2.  Diagnosis and management of porphyria.

Authors:  H Thadani; A Deacon; T Peters
Journal:  BMJ       Date:  2000-06-17

3.  [A 25-year-old patient with colonic pseudo-obstruction, hyponatremia, hypertension, and diffuse pain].

Authors:  Philipp Lutz; Daniel Maring; Henriette J Tschampa; Tilman Sauerbruch
Journal:  Med Klin (Munich)       Date:  2010-04

4.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Authors:  H Puy; J C Deybach; J Lamoril; A M Robreau; V Da Silva; L Gouya; B Grandchamp; Y Nordmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 6.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

7.  Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria.

Authors:  G Lundin; J Hashemi; Y Floderus; S Thunell; E Sagen; A Laegreid; W Wassif; T Peters; M Anvret
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

8.  Detection of eleven mutations causing acute intermittent porphyria using denaturing gradient gel electrophoresis.

Authors:  X F Gu; F de Rooij; G Voortman; K Te Velde; J C Deybach; Y Nordmann; B Grandchamp
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

9.  Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR amplification of specific alleles.

Authors:  G Lundin; A Wedell; S Thunell; M Anvret
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

10.  Frameshift mutations in exons 9 and 10 of the porphobilinogen deaminase gene produce a crossreacting immunological material (CRIM)-negative form of acute intermittent porphyria.

Authors:  W E Schreiber; F Fong; A Jamani
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.